South Africa’s Department of Health reports that more than 55,000 people have started twice-yearly lenacapavir pre-exposure prophylaxis (PrEP) by 7 September. Among those new initiations, women make up 71%, according to the department.
The health ministry says pregnant and breastfeeding women are among the priority groups for lenacapavir PrEP, which helps explain the higher share of female users in new starts. The figures are drawn from programme data compiled by the Department of Health.
With limited detail in the available reporting, outlets focus on the same core points: the scale of uptake, the 71% female share of new initiations, and the policy emphasis on maternal and child health groups. No other differing angles or claims are provided in the supplied source.
